BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talebi Bezmin Abadi A. Therapy of Helicobacter pylori: present medley and future prospective. Biomed Res Int. 2014;2014:124607. [PMID: 24800203 DOI: 10.1155/2014/124607] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Talebi Bezmin Abadi A. Helicobacter pylori: Emergence of a Superbug. Front Med (Lausanne). 2014;1:34. [PMID: 25593908 DOI: 10.3389/fmed.2014.00034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
2 Hu D, Zhang F, Zhou J, Xu B, Zhang H, Qiang H, Ren S, Shan B, Yin C, Zhang Z, Wang X, Zhao C, Shi Z. The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial. J Transl Med 2015;13:205. [PMID: 26123101 DOI: 10.1186/s12967-015-0558-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Talebi Bezmin Abadi A. Vaccine against Helicobacter pylori: Inevitable approach. World J Gastroenterol 2016; 22(11): 3150-3157 [PMID: 27003991 DOI: 10.3748/wjg.v22.i11.3150] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
4 Ierardi E, Losurdo G, Giorgio F, Iannone A, Principi M, Leo AD. Quinolone-based first, second and third-line therapies for Helicobacter pyloriWorld J Pharmacol 2015; 4(4): 274-280 [DOI: 10.5497/wjp.v4.i4.274] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Talebi Bezmin Abadi A. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017;8:123-30. [DOI: 10.1016/j.jgar.2016.11.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
6 Talebi Bezmin Abadi A. Helicobacter pylori and Gastric Cancer. Front Med (Lausanne) 2016;3:36. [PMID: 27597945 DOI: 10.3389/fmed.2016.00036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
7 Alvi A. In response to "Conclusive strategies for therapy and virotyping of Helicobacter pylori". Saudi J Gastroenterol 2014;20:326. [PMID: 25384332 DOI: 10.4103/1319-3767.141701] [Reference Citation Analysis]
8 Talebi Bezmin Abadi A, Yamaoka Y. Helicobacter pylori therapy and clinical perspective. Journal of Global Antimicrobial Resistance 2018;14:111-7. [DOI: 10.1016/j.jgar.2018.03.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
9 Allison R, Lecky DM, Bull M, Turner K, Godbole G, McNulty CA. Audit of Helicobacter pylori Testing in Microbiology Laboratories in England: To Inform Compliance with NICE Guidance and the Feasibility of Routine Antimicrobial Resistance Surveillance. Int J Microbiol 2016;2016:8540904. [PMID: 27829836 DOI: 10.1155/2016/8540904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Abadi AT, Mobarez AM, Teymournejad O, Karbalaei M. Concomitant Colonization of Helicobacter pylori in Dental Plaque and Gastric Biopsy. J Pathog. 2014;2014:871601. [PMID: 25120932 DOI: 10.1155/2014/871601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zhao Y, Ren M, Wang X, Lu G, Lu X, Zhang D, He S. Telephone-Based Reeducation of Drug Administration for Helicobacterpylori Eradication: A Multicenter Randomized Controlled Study. Gastroenterol Res Pract 2020;2020:8972473. [PMID: 32802048 DOI: 10.1155/2020/8972473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Abadi AT, Mobarez AM. Conclusive strategies for therapy and virotyping of Helicobacter pylori. Saudi J Gastroenterol 2014;20:325. [PMID: 25253371 DOI: 10.4103/1319-3767.141699] [Reference Citation Analysis]
13 Hajaghamohammadi A, Safiabadi Tali SH, Samimi R, Oveisi S, Kazemifar AM. Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial. Glob J Health Sci 2014;7:235-9. [PMID: 25560342 DOI: 10.5539/gjhs.v7n1p235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
14 Buzás GM. [Helicobacter pylori -- 2014]. Orv Hetil 2015;156:203-10. [PMID: 25639633 DOI: 10.1556/OH.2015.30097] [Reference Citation Analysis]
15 Losurdo G, Giorgio F, Iannone A, Principi M, Barone M, Di Leo A, Ierardi E. Role of concomitant therapy for Helicobacter pylori eradication: A technical note. World J Gastroenterol 2016; 22(38): 8638-8640 [PMID: 27784977 DOI: 10.3748/wjg.v22.i38.8638] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Talebi Bezmin Abadi A. Helicobacter pylori: A Beneficial Gastric Pathogen? Front Med (Lausanne) 2014;1:26. [PMID: 25593901 DOI: 10.3389/fmed.2014.00026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
17 Talebi Bezmin Abadi A, Perez-Perez G. Role of dupA in virulence of Helicobacter pyloriWorld J Gastroenterol 2016; 22(46): 10118-10123 [PMID: 28028359 DOI: 10.3748/wjg.v22.i46.10118] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
18 Talebi Bezmin Abadi A. Not an easy road to generate an effective Helicobacter pylori vaccine. Infect Genet Evol 2017;51:45. [PMID: 28300649 DOI: 10.1016/j.meegid.2017.03.010] [Reference Citation Analysis]
19 Abadi AT, Kusters JG. Management of Helicobacter pylori infections. BMC Gastroenterol. 2016;16:94. [PMID: 27520775 DOI: 10.1186/s12876-016-0496-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
20 Talebi Bezmin Abadi A. The Helicobacter pylori dupA: A Novel Biomarker for Digestive Diseases. Front Med (Lausanne). 2014;1:13. [PMID: 25767798 DOI: 10.3389/fmed.2014.00013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]